Невидимая угроза. Как Wi-Fi, сотовые телефоны, 5G и другие электромагнитные излучения влияют на наше самочувствие и продолжительность жизни

145. Feng Y, Chu A, Luo Q, Wu M, Shi X, Chen Y. “The Protective Effect of Astaxanthin on Cognitive Function via Inhibition of Oxidative Stress and Inflammation in the Brains of Chronic T2DM Rats.” Frontiers in Pharmacology. Vol. 9. (July 2018): 748. doi: 10.3389/fphar.2018.00748.

146. Saito H. “Toxico-Pharmacological Perspective of the Nrf2-Keap1 Defense System against Oxidative Stress in Kidney Diseases.” Biochemical Pharmacology. Vol. 85, no. 7. (April 2013): 865–872. doi: 10.1016/j.bcp.2013.01.006.

147. Pedruzzi LM, Stockler-Pinto MB, Leite M Jr, Mafra D. “Nrf2-keap1 System Versus NF-κB: The Good and the Evil in Chronic Kidney Disease?” Biochimie. Vol. 94, no. 12. (December 2012): 2461–2466. doi: 10.1016/j.biochi.2012.07.015.

148. Loboda A, Rojczyk-Golebiewska E, Bednarczyk-Cwynar B, Lucjusz Z, Jozkowicz A, Dulak J. “Targeting nrf2-Mediated Gene Transcription by Triterpenoids and Their Derivatives.” Biomolecules & Therapeutics (Seoul). Vol. 20. (2012): 499–505. doi: 10.4062/biomolther.2012.20.6.499.

149. Vomhof-Dekrey EE, Picklo MJ Sr. “The Nrf2-Antioxidant Response Element Pathway: A Target for Regulating Energy Metabolism.” Journal of Nutritional Biochemistry. Vol. 23, no. 10. (October 2012): 1201–1206. doi: 10.1016/j.jnutbio.2012.03.005.

150. Liby KT, Sporn MB. “Synthetic Oleanane Triterpenoids: Multifunctional Drugs with a Broad Range of Applications for Prevention and Treatment of Chronic Disease.” Pharmacological Reviews. Vol. 64, no. 4. (October 2012): 972–1003. doi: 10.1124/pr.111.004846.

151. Jiang XY, Zhu XS, Xu HY, Zhao ZX, Li SY, Li SZ, Cai JH, Cao JM. “Diallyl Trisulfide Suppresses Tumor Growth through the Attenuation of Nrf2/Akt and Activation of p38/JNK and Potentiates Cisplatin Efficacy in Gastric Cancer Treatment.” Acta Pharmacologica Sinica. Vol. 38, no. 7. (July 2017): 1048–1058. doi: 10.1038/aps.2016.176.

152. Yang CM, Huang SM, Liu CL, Hu ML. “Apo-8’-Lycopenal Induces Expression of HO-1 and NQO-1 via the ERK/p38-Nrf2-ARE Pathway in Human HepG2 Cells.” Journal of Agricultural and Food Chemistry. Vol. 60, no. 6. (February 2012): 1576–1585. doi: 10.1021/jf204451n.

153. Linnewiel K, Ernst H, Caris-Veyrat C, Ben-Dor A, Kampf A, Salman H, Danilenko M, Levy J, Sharoni Y. “Structure Activity Relationship of Carotenoid Derivatives in Activation of the Electrophile/Antioxidant Response Element Transcription System.” Free Radical Biology & Medicine. Vol. 47, no. 5. (September 2009): 659–667.

154. Zhang M, Wang S, Mao L, Leak RK, Shi Y, Zhang W, Hu X, Sun B, Cao G, Gao Y, Xu Y, Chen J, Zhang F. “Omega-3 Fatty Acids Protect the Brain against Ischemic Injury by Activating Nrf2 and Upregulating Heme Oxygenase 1.” Journal of Neuroscience. Vol. 34. (2014): 1903–1915. doi: 10.1016/j.freeradbiomed.2009.06.008.

155. Nakagawa F, Morino K, Ugi S, Ishikado A, Kondo K, Sato D, Konno S, Nemoto K, Kusunoki C, Sekine O, Sunagawa A, Kawamura M, Inoue N, Nishio Y, Maegawa H. “4-Hydroxy Hexenal Derived from Dietary n-3 Polyunsaturated Fatty Acids Induces Anti-Oxidative Enzyme Heme Oxygenase-1 in Multiple Organs.” Biochemistry and Biophysical Research Communications. Vol. 43. (2014): 991–996. doi: 10.1016/j.bbrc.2013.12.085.

156. Maher J, Yamamoto M. “The Rise of Antioxidant Signaling – The Evolution and Hormetic Actions of Nrf2.” Toxicology in Applied Pharmacology. Vol. 244, no. 1. (April 2010): 4–15.

157. Ahmadi Z, Ashrafizadeh M. “Melatonin as a Potential Modulator of Nrf2.” Fundamental & Clinical Pharmacology. (July 8, 2019). doi: 10.1111/fcp.12498.

158. Uwitonze AM, Razzaque MS. “Role of Magnesium in Vitamin D Activation and Function.” Journal of the American Osteopathic Association. Vol. 118, no. 3. (March 1, 2018): 181–189. doi: 10.7556/jaoa.2018.037.

159. Houston M. “The Role of Magnesium in Hypertension and Cardiovascular Disease.” Journal of Clinical Hypertension (Greenwich). Vol. 13, no. 11. (November 2011): 843–847. doi: 10.1111/j.1751–7176.2011.00538.x.

160. Bertinato J. “Magnesium Deficiency: Prevalence, Assessment, and Physiological Effects.” Handbook of Famine, Starvation, and Nutrient Deprivation. December 2016. doi: 10.1007/978-3-319-40007-5_6-1.

161. Liu G, Weinger JG, Lu ZL, Xue F, Sadeghpour S. “Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.” Journal of Alzheimer’s Disease. Vol. 49, no. 4. (2016): 971–990.